Fed. Circ. Blocks Courts From Fixing Overbroad Use Codes
When a branded drug company is found to have listed a use code for a product that overstates the scope of a patent, courts cannot order specific changes the company must...To view the full article, register now.
Already a subscriber? Click here to view full article